Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy, Conformal | 10 | 2007 | 548 | 1.010 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 7 | 2007 | 1624 | 0.410 |
Why?
|
| Radiometry | 5 | 2007 | 800 | 0.380 |
Why?
|
| Radiation Tolerance | 2 | 2021 | 486 | 0.270 |
Why?
|
| Movement | 4 | 2004 | 1471 | 0.190 |
Why?
|
| Artifacts | 3 | 2007 | 1904 | 0.160 |
Why?
|
| Metals | 1 | 2001 | 719 | 0.140 |
Why?
|
| Recombinases | 1 | 2016 | 67 | 0.140 |
Why?
|
| Protons | 2 | 2021 | 1127 | 0.120 |
Why?
|
| Respiration | 5 | 2004 | 1653 | 0.120 |
Why?
|
| Hip Prosthesis | 1 | 2001 | 917 | 0.120 |
Why?
|
| Relative Biological Effectiveness | 1 | 2016 | 323 | 0.120 |
Why?
|
| DNA Replication | 1 | 2021 | 1399 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1692 | 0.110 |
Why?
|
| Radiotherapy Dosage | 6 | 2009 | 2879 | 0.110 |
Why?
|
| Endonucleases | 1 | 2016 | 380 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 594 | 0.100 |
Why?
|
| Phantoms, Imaging | 4 | 2004 | 2480 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
| Motion | 2 | 2004 | 798 | 0.080 |
Why?
|
| Models, Theoretical | 4 | 2007 | 3589 | 0.080 |
Why?
|
| Algorithms | 3 | 2003 | 13881 | 0.080 |
Why?
|
| DNA Repair | 1 | 2016 | 2046 | 0.070 |
Why?
|
| Computer-Aided Design | 1 | 2007 | 298 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 868 | 0.060 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 19905 | 0.060 |
Why?
|
| Extremities | 1 | 2009 | 865 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 280 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2003 | 13102 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2007 | 6196 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 2001 | 101 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 1363 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2021 | 358 | 0.040 |
Why?
|
| Calibration | 1 | 2001 | 816 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2003 | 4042 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9648 | 0.040 |
Why?
|
| Sarcoma | 1 | 2009 | 1897 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 11124 | 0.040 |
Why?
|
| Cesium Radioisotopes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Cobalt Radioisotopes | 1 | 2016 | 76 | 0.030 |
Why?
|
| Software | 2 | 2000 | 4443 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 189 | 0.030 |
Why?
|
| Neoplasms | 2 | 2021 | 21683 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2016 | 165 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 14722 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2001 | 1172 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2002 | 1928 | 0.030 |
Why?
|
| Phthalazines | 1 | 2016 | 363 | 0.030 |
Why?
|
| Fanconi Anemia | 1 | 2016 | 319 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.030 |
Why?
|
| Particle Accelerators | 2 | 2003 | 173 | 0.030 |
Why?
|
| Prostate | 1 | 2001 | 1774 | 0.030 |
Why?
|
| Radiography | 1 | 2003 | 7023 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2007 | 20129 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5078 | 0.020 |
Why?
|
| Quality Control | 2 | 2003 | 841 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2000 | 2212 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4253 | 0.020 |
Why?
|
| Humans | 13 | 2021 | 744343 | 0.020 |
Why?
|
| DNA | 1 | 2021 | 7301 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5256 | 0.020 |
Why?
|
| Models, Biological | 1 | 2002 | 9583 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 498 | 0.020 |
Why?
|
| Linear Models | 1 | 2016 | 5952 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10481 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16689 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2009 | 1915 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 327 | 0.010 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2002 | 94 | 0.010 |
Why?
|
| Biophysics | 1 | 2003 | 383 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 876 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2250 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2004 | 924 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2004 | 516 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 1254 | 0.010 |
Why?
|
| Models, Statistical | 2 | 2003 | 5102 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29786 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81183 | 0.010 |
Why?
|
| Male | 2 | 2009 | 350118 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15295 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 57776 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 5221 | 0.000 |
Why?
|
| Animals | 1 | 2016 | 168757 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 56430 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 85781 | 0.000 |
Why?
|
| Aged | 1 | 2009 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2009 | 213383 | 0.000 |
Why?
|
| Adult | 1 | 2009 | 214055 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2004 | 77449 | 0.000 |
Why?
|
| Female | 1 | 2009 | 380194 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_